SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
12153919
Source:
http://linkedlifedata.com/resource/pubmed/id/12153919
Search
Subject
(
92
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0011847
,
umls-concept:C0027775
,
umls-concept:C0030705
,
umls-concept:C0031809
,
umls-concept:C0032659
,
umls-concept:C0035647
,
umls-concept:C0036341
,
umls-concept:C0073393
,
umls-concept:C0085862
,
umls-concept:C0171023
,
umls-concept:C1280500
,
umls-concept:C1299583
,
umls-concept:C1527178
,
umls-concept:C1549571
,
umls-concept:C1608386
,
umls-concept:C1705938
pubmed:issue
7358
pubmed:dateCreated
2002-8-2
pubmed:abstractText
To quantify the association between olanzapine and diabetes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10213569
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10360147
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10484968
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10553730
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10578454
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10584769
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10928397
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-10975220
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-11013323
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-11078035
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-11358771
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-11769820
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-12561827
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-13408103
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-2908235
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-3052818
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-5634402
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-6146346
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-6801979
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-7872581
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-8343670
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-9798083
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/12153919-9921705
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8900488
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Pirenzepine
,
http://linkedlifedata.com/resource/pubmed/chemical/Risperidone
,
http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1468-5833
pubmed:author
pubmed-author:BuchananRobert WRW
,
pubmed-author:FedderDonald ODO
,
pubmed-author:KoroCarol ECE
,
pubmed-author:KreyenbuhlJulieJ
,
pubmed-author:L'ItalienGilbert JGJ
,
pubmed-author:MagderLaurence SLS
,
pubmed-author:RevickiDennis ADA
,
pubmed-author:WeissSheila SSS
pubmed:issnType
Electronic
pubmed:day
3
pubmed:volume
325
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
243
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:12153919-Adult
,
pubmed-meshheading:12153919-Aged
,
pubmed-meshheading:12153919-Antipsychotic Agents
,
pubmed-meshheading:12153919-Benzodiazepines
,
pubmed-meshheading:12153919-Case-Control Studies
,
pubmed-meshheading:12153919-Cohort Studies
,
pubmed-meshheading:12153919-Diabetes Mellitus
,
pubmed-meshheading:12153919-Female
,
pubmed-meshheading:12153919-Follow-Up Studies
,
pubmed-meshheading:12153919-Humans
,
pubmed-meshheading:12153919-Male
,
pubmed-meshheading:12153919-Middle Aged
,
pubmed-meshheading:12153919-Odds Ratio
,
pubmed-meshheading:12153919-Pirenzepine
,
pubmed-meshheading:12153919-Regression Analysis
,
pubmed-meshheading:12153919-Risk Factors
,
pubmed-meshheading:12153919-Risperidone
,
pubmed-meshheading:12153919-Schizophrenia
pubmed:year
2002
pubmed:articleTitle
Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.
pubmed:affiliation
Pharmaceutical Health Services Research Department, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA.
pubmed:publicationType
Journal Article
,
Comparative Study